Amgen Inc. (AMGN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Amgen Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.487 -- 00:00:05.334 My name is Julianne and I will be your conference facilitator today for the Amgen Q1 00:00:05.334 -- 00:00:08.699 FY 2025 earnings conference call. 00:00:08.699 -- 00:00:12.083 All lines have been placed on mute to prevent any background noise. 00:00:12.083 -- 00:00:15.668 There will be a question and answer session at the conclusion of the last speaker's prepared 00:00:15.668 -- 00:00:17.090 remarks. 00:00:17.090 -- 00:00:20.755 In order to ensure that everyone has a chance to participate, we would like to request 00:00:20.755 -- 00:00:24.481 that you limit yourself to asking one question during the Q&A session. 00:00:24.481 -- 00:00:28.837 To ask a question, please press star then the number one on your telephone keypad. 00:00:28.837 -- 00:00:30.879 To withdraw your question, please press star 1 again. 00:00:30.879 -- 00:00:35.844 I would now like to introduce Justin Clays, Vice President of Investor Relations. 00:00:35.844 -- 00:00:38.587 Mr. Clays, you may now begin. 00:00:38.587 -- 00:00:42.991 Good afternoon, and welcome to our first quarter 2025 earnings call. 00:00:42.991 -- 00:00:46.655 Bob Bradley will lead the call and be followed by a broader review of our performance 00:00:46.655 -- 00:00:50.018 by Myrtle Gordon, Jay Bradner, and Peter Griffith. 00:00:50.018 -- 00:00:53.622 Through the course of our discussion today, we will use non-GAAP financial measures to 00:00:53.622 -- 00:00:57.898 describe our performance, and have provided appropriate reconciliations within the materials 00:00:57.898 -- 00:01:01.944 that accompany this call. We will also make some forward-looking statements, which are 00:01:01.944 -- 00:01:06.251 qualified by our Safe Harbor Statement, and please note that actual results can vary 00:01:06.251 -...